Purchase Order 75N90025P00680
- Not listed
- This is a $16,030.84 firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions. The contract is for the procurement of licensing for web access to Qiagen's Ingenuity Pathway Analysis software. This contract was not set aside and does not appear to be associated with a larger contract vehicle. Qiagen has a history...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed-price purchase order to Qiagen, LLC, a division of the international provider Qiagen N.V., to provide IPA (Ingenuity Pathway Analysis) Analysis Match Explorer CL software licenses. The contract has a potential value of $139,495.00 and a performance period ending on August 31, 2023. This award does not utilize any set-aside designations. Qiagen has a history of...
- This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, to Qiagen, LLC for software licenses for NIDDK's IPA (Ingenuity Pathway Analysis) software. The contract has a ceiling value of $31,733.00 and a period of performance through September 28, 2025. Qiagen is a global provider of molecular diagnostics, applied testing, and bioinformatics...
- Qiagen, LLC has been awarded a firm fixed-price purchase order valued at $39,252 by a civilian agency within the Northeast Area for a limited concurrent license of QIAGEN Ingenuity Pathway Analysis (IPA) software. This bioinformatics tool is designed to identify and predict master regulators in complex biological systems, enabling researchers to quickly understand diseases, phenotypes, and associated genes. The contract was awarded on March 1, 2025, with an ultimate completion date of March 4,...
- This firm-fixed-price purchase order contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Qiagen, LLC, a division of the international provider Qiagen N.V. The $126,230.40 contract is for IPA (Ingenuity Pathway Analysis) analysis services, with a completion date of January 31, 2020. Qiagen has previously provided a range of goods and services, including DNA/RNA extraction kits,...
- This federal contract award is for the maintenance and renewal of software from Qiagen Inc. for the National Institutes of Health (NIH) Clinical Center. The contract, valued at $19,229.00, has a firm fixed-price structure and an ultimate completion date of August 28, 2026. Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions, is the prime contractor. This contract does not have a set-aside designation. Qiagen is a...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) Clinical Center awarded a $17,600.00 firm fixed price purchase order to Qiagen, LLC, a division of the international life sciences company Qiagen N.V. The contract is for the renewal of a data analysis software license and has a completion date of March 30, 2025. Qiagen is a provider of sample and assay technologies that supports federal agencies' biomedical research, public health, law enforcement, and...
- This is a $22,536 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Qiagen, LLC, a subsidiary of the international biotechnology company Qiagen N.V. The contract is for IPA (Ingenuity Pathway Analysis) software licenses and LCL (local community) group licenses. Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academic research, and has held numerous federal...
- This is a $10,768 firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for the provision of Qiagen's clinical insight analysis products and services, with a period of performance through September 28, 2026. Qiagen, a foreign-owned, for-profit manufacturer, specializes in molecular diagnostics, scientific equipment, and bioinformatics solutions. The...
- The National Institute of Environmental Health Sciences (NIEHS), a civilian federal agency, has awarded a firm-fixed-price purchase order contract to Qiagen, LLC, a foreign-owned for-profit manufacturer, for an Ingenuity Pathway Analysis software support subscription. The contract has a ceiling value of $243,646.00 and a period of performance through December 31, 2025. Qiagen is an experienced federal contractor that has provided a range of products and services to support biomedical research,...
Qiagen, LLC has been awarded a firm fixed price purchase order valued at $19,237.01 by the NIH Clinical Center for QIAGEN Ingenuity Pathway Analysis software. The award, issued September 4, 2025, carries an ultimate completion date of October 4, 2025. This contract represents a direct procurement with no set-aside designation, reflecting Qiagen's competitive standing in the open federal marketplace. The place of performance is Germantown, Maryland, where Qiagen maintains its U.S. headquarters. The Ingenuity Pathway Analysis software is a bioinformatics tool that supports genomic data interpretation and molecular analysis, aligning with the NIH Clinical Center's mission to conduct and support medical research. Qiagen's provision of this software license supports the Clinical Center's research capabilities in molecular diagnostics and precision medicine applications. As a global provider of molecular diagnostics and bioinformatics solutions, Qiagen maintains an extensive contract portfolio across multiple federal agencies, including the NIH, CDC, VA, and DOD, delivering specialized laboratory equipment, reagents, diagnostic testing kits, and software solutions for advanced scientific research and healthcare initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.2k | 9/4/25 |